Marco Salvetti

18.5k total citations · 3 hit papers
167 papers, 5.7k citations indexed

About

Marco Salvetti is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, Marco Salvetti has authored 167 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Pathology and Forensic Medicine, 48 papers in Immunology and 38 papers in Neurology. Recurrent topics in Marco Salvetti's work include Multiple Sclerosis Research Studies (82 papers), Immunotherapy and Immune Responses (29 papers) and T-cell and B-cell Immunology (22 papers). Marco Salvetti is often cited by papers focused on Multiple Sclerosis Research Studies (82 papers), Immunotherapy and Immune Responses (29 papers) and T-cell and B-cell Immunology (22 papers). Marco Salvetti collaborates with scholars based in Italy, United States and United Kingdom. Marco Salvetti's co-authors include Giovanni Ristori, Francesca Aloisi, Rosella Mechelli, Barbara Serafini, Maria Chiara Buscarinu, Silvia Romano, Viviana Annibali, Giulia Coarelli, Richard Reynolds and Luca Battistini and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Nature Immunology.

In The Last Decade

Marco Salvetti

157 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain

2007 557 citations Barbara Serafini, Barbara Rosicarelli et al. The Journal of Experimental Medicine profile →
A “Candidate-Interactome” Aggregate Analysis of Genome-Wide Association Data in Multiple Sclerosis

2013 473 citations Rosella Mechelli, Renato Umeton et al. PLoS ONE profile →
Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

2021 296 citations Maria Pia Sormani, Nicola De Rossi et al. Annals of Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marco Salvetti Italy	37	2.3k	1.9k	1.1k	1.1k	914	167	5.7k
Lisa F. Barcellos United States	49	3.2k 1.4×	2.7k 1.5×	2.2k 2.0×	452 0.4×	877 1.0×	157	8.1k
Adam E. Handel United Kingdom	27	1.6k 0.7×	818 0.4×	869 0.8×	486 0.4×	390 0.4×	85	3.9k
Michael Bergmann Austria	43	689 0.3×	1.3k 0.7×	2.0k 1.8×	346 0.3×	1.3k 1.4×	268	6.8k
Giovanni Ristori Italy	30	729 0.3×	1.1k 0.6×	918 0.8×	404 0.4×	290 0.3×	102	3.3k
Peter Rieckmann Germany	64	6.8k 3.0×	3.1k 1.7×	2.2k 2.0×	2.9k 2.6×	2.4k 2.6×	266	13.1k
Hua Liu China	52	508 0.2×	969 0.5×	4.3k 3.9×	656 0.6×	1.0k 1.1×	373	9.7k
Jeanine J. Houwing‐Duistermaat Netherlands	48	490 0.2×	988 0.5×	2.1k 1.9×	371 0.3×	515 0.6×	231	6.9k
Teresa Corona Mexico	25	1.3k 0.6×	578 0.3×	932 0.8×	456 0.4×	192 0.2×	144	3.0k
Mark W. Kieran United States	65	864 0.4×	2.5k 1.3×	6.7k 6.1×	2.5k 2.3×	2.7k 2.9×	268	14.9k
Lynn R. Goldin United States	54	1.6k 0.7×	1.3k 0.7×	2.7k 2.5×	240 0.2×	1.2k 1.3×	192	8.6k

Countries citing papers authored by Marco Salvetti

Since Specialization

Citations

This map shows the geographic impact of Marco Salvetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Salvetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Salvetti more than expected).

Fields of papers citing papers by Marco Salvetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Salvetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Salvetti. The network helps show where Marco Salvetti may publish in the future.

Co-authorship network of co-authors of Marco Salvetti

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Salvetti. A scholar is included among the top collaborators of Marco Salvetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Salvetti. Marco Salvetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bianchini, Edoardo, Marika Alborghetti, S. Galli, et al.. (2025). Minimal Clinically Important Difference of Average Daily Steps Measured Through a Consumer Smartwatch in People With Mild-to-Moderate Parkinson Disease: Cross-Sectional Study. JMIR mhealth and uhealth. 13. e64213–e64213.

Bellucci, Gianmarco, M. Betti, Valeria Penati, et al.. (2025). Exploring the role of EBV in multiple sclerosis pathogenesis through EBV interactome. Frontiers in Immunology. 16. 1557483–1557483. 1 indexed citations

Rinaldi, Virginia, A. Marrone, Roberta Reniè, et al.. (2024). Clinical and Immunological Impact of Ocrelizumab Extended Interval Dosing in Multiple Sclerosis: A Single-Center, Real-World Experience. International Journal of Molecular Sciences. 25(10). 5353–5353. 7 indexed citations

Ferrazzano, Gina, Daniele Belvisi, Giorgio Leodori, et al.. (2024). Exploring miRNAs’ Based Modeling Approach for Predicting PIRA in Multiple Sclerosis: A Comprehensive Analysis. International Journal of Molecular Sciences. 25(12). 6342–6342. 1 indexed citations

Bigi, Riccardo, Roberta Reniè, Maria Chiara Buscarinu, et al.. (2024). Gut Microbiota Composition Is Causally Linked to Multiple Sclerosis: A Mendelian Randomization Analysis. Microorganisms. 12(7). 1476–1476. 1 indexed citations

Morena, Emanuele, Carmela Romano, Maria Chiara Buscarinu, et al.. (2023). Peripheral Biomarkers in Manifest and Premanifest Huntington’s Disease. International Journal of Molecular Sciences. 24(7). 6051–6051. 15 indexed citations

Severa, Martina, Fabiana Rizzo, Alessandro Sinigaglia, et al.. (2023). A specific anti‐COVID‐19 BNT162b2 vaccine‐induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis vaccine recipients. Clinical & Translational Immunology. 12(3). e1434–e1434. 4 indexed citations

Leonardi, Luca, Giuseppe Di Pietro, Antonella Di Pasquale, et al.. (2021). High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP. Neurological Sciences. 43(5). 3387–3394. 7 indexed citations

Sormani, Maria Pia, Nicola De Rossi, Irene Schiavetti, et al.. (2021). Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis. Annals of Neurology. 89(4). 780–789. 296 indexed citations breakdown →

10.

Lucchini, Matteo, Luca Prosperini, Maria Chiara Buscarinu, et al.. (2021). Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis. Journal of Neurology. 268(6). 2238–2245. 12 indexed citations

11.

Sormani, Maria Pia, Nicola De Rossi, Irene Schiavetti, et al.. (2021). Different disease modifying therapies can increase or decrease Covid-19 severity in Multiple Sclerosis (2021). Neurology. 96(15_supplement). 4 indexed citations

12.

Bassi, Mario Stampanoni, Fabio Buttari, Ilaria Simonelli, et al.. (2020). A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment. Genes. 11(10). 1152–1152. 6 indexed citations

13.

Leonardi, Luca, Fiammetta Vanoli, Laura Fionda, et al.. (2020). Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy. Neurological Sciences. 41(12). 3775–3778. 7 indexed citations

14.

Mechelli, Rosella, Renato Umeton, Claudia Policano, et al.. (2013). A “Candidate-Interactome” Aggregate Analysis of Genome-Wide Association Data in Multiple Sclerosis. PLoS ONE. 8(5). e63300–e63300. 473 indexed citations breakdown →

15.

Villani, Veronica, Laura De Giglio, Giuliano Sette, et al.. (2012). Determinants of the severity of comorbid migraine in multiple sclerosis. Neurological Sciences. 33(6). 1345–1353. 12 indexed citations

16.

Serafini, Barbara, Barbara Rosicarelli, Diego Franciotta, et al.. (2007). Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. The Journal of Experimental Medicine. 204(12). 2899–2912. 557 indexed citations breakdown →

17.

Forte, Giovanni, Andrea Visconti, Anna Ghazaryan, et al.. (2005). Quantification of chemical elements in blood of patients affected by multiple sclerosis.. IRIS Research product catalog (Sapienza University of Rome). 41(2). 213–6. 40 indexed citations

18.

Stazi, Maria Antonietta, Rodolfo Cotichini, M Patriarca, et al.. (2002). The Italian Twin Project: From the Personal Identification Number to a National Twin Registry. Twin Research. 5(5). 382–386. 46 indexed citations

19.

Ristori, Giovanni, Paolo Stacchini, Claudio Gasperini, et al.. (1998). Serum amyloid A protein is elevated in relapsing–remitting multiple sclerosis. Journal of Neuroimmunology. 88(1-2). 9–12. 26 indexed citations

20.

Millefiorini, Enrico, Mario Di Giovanni, Silvia Bernardi, et al.. (1990). Cyclophosphamide in the therapy of multiple sclerosis: A longitudinal study on intrathecal immunoglobulin response. International Journal of Immunopathology and Pharmacology. 3(1). 59–62.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact